Maiden Pharma denies tampering with tests in probe of cough syrup deaths

Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana's Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news